vs
Side-by-side financial comparison of ASTRAZENECA PLC (AZN) and Innate Pharma SA (IPHA). Click either name above to swap in a different company.
AstraZeneca plc (AZ) is a Swedish-British multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, UK. It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation.
aTyr Pharma is a public biotherapeutics company that is focused on researching the extracellular functionality and signaling pathways of tRNA synthetases.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q2 25 | $14.5B | — | ||
| Q2 24 | $12.9B | — | ||
| Q2 23 | $11.4B | — | ||
| Q2 22 | $10.8B | — |
| Q2 25 | $2.4B | — | ||
| Q2 24 | $1.9B | — | ||
| Q2 23 | $1.8B | — | ||
| Q2 22 | $360.0M | — |
| Q2 25 | 82.9% | — | ||
| Q2 24 | 83.1% | — | ||
| Q2 23 | 82.8% | — | ||
| Q2 22 | 72.2% | — |
| Q2 25 | 24.3% | — | ||
| Q2 24 | 21.2% | — | ||
| Q2 23 | 21.5% | — | ||
| Q2 22 | 5.0% | — |
| Q2 25 | 16.9% | — | ||
| Q2 24 | 14.9% | — | ||
| Q2 23 | 15.9% | — | ||
| Q2 22 | 3.3% | — |
| Q2 25 | $1.57 | — | ||
| Q2 24 | $1.24 | — | ||
| Q2 23 | $1.17 | — | ||
| Q2 22 | $0.23 | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
